Drawing for BLOOD

USPTO serial 74563996

BLOOD

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
MAJOR, SCOTT J.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BLOOD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
028computer game softwareABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 1997ABN1ABANDONMENT - EXPRESS MAILED
Mar 14, 1997EX3GSOU EXTENSION 3 GRANTED
Dec 27, 1996EXT3SOU EXTENSION 3 FILED
Sep 22, 1996EX2GSOU EXTENSION 2 GRANTED
Jul 22, 1996EXT2SOU EXTENSION 2 FILED
May 13, 1996EX1GSOU EXTENSION 1 GRANTED
Feb 26, 1996EXT1SOU EXTENSION 1 FILED
Aug 29, 1995NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 6, 1995PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 1995NPUBNOTICE OF PUBLICATION
Jan 20, 1995CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 1995DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance